HEADER ISOMERASE 15-OCT-07 2RJR TITLE SUBSTRATE MIMIC BOUND TO SGTAM CAVEAT 2RJR INCORRECT CHIRALITY AT GLN 537 CA COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE AMINOMUTASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TYROSINE AMINOMUTASE; COMPND 5 SYNONYM: PUTATIVE AMMONIA LYASE/TRANSFERASE; COMPND 6 EC: 5.4.3.6; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES GLOBISPORUS; SOURCE 3 ORGANISM_TAXID: 1908; SOURCE 4 GENE: SGCC4; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS 4-METHYLIDENE IMIDIZOLE, MIO, AMINOMUTASE, C-1027, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.J.MONTAVON,C.V.CHRISTIANSON,S.D.BRUNER REVDAT 7 15-NOV-23 2RJR 1 LINK ATOM REVDAT 6 30-AUG-23 2RJR 1 REMARK LINK REVDAT 5 25-OCT-17 2RJR 1 REMARK REVDAT 4 16-NOV-11 2RJR 1 VERSN HETATM REVDAT 3 24-FEB-09 2RJR 1 VERSN REVDAT 2 22-JUL-08 2RJR 1 JRNL LINK REMARK REVDAT 1 15-JAN-08 2RJR 0 JRNL AUTH T.J.MONTAVON,C.V.CHRISTIANSON,G.M.FESTIN,B.SHEN,S.D.BRUNER JRNL TITL DESIGN AND CHARACTERIZATION OF MECHANISM-BASED INHIBITORS JRNL TITL 2 FOR THE TYROSINE AMINOMUTASE SGTAM. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 3099 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18078753 JRNL DOI 10.1016/J.BMCL.2007.11.046 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 57077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.700 REMARK 3 FREE R VALUE TEST SET COUNT : 5782 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.4070 REMARK 3 BIN FREE R VALUE : 0.4490 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8014 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 473 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.42000 REMARK 3 B22 (A**2) : 2.37900 REMARK 3 B33 (A**2) : -1.95800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.145 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.668 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.057 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.922 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 71.30 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP_MDO_7.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : DIO_101007.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RJR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000044943. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAY-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X26C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(111) CRYSTAL REMARK 200 OPTICS : CHANNEL-CUT SI(111) CRYSTAL REMARK 200 MONOCHROMATOR FOLLOWED BY A REMARK 200 DOUBLY FOCUSING TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59059 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : 0.44900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2OHY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4.4 M SODIUM FORMATE, 100 MM TMAO, PH REMARK 280 9.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 46.12250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 72.82400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 46.12250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 72.82400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 33640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 54160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -163.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 737 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 LEU A 3 REMARK 465 THR A 4 REMARK 465 GLN A 5 REMARK 465 VAL A 6 REMARK 465 GLU A 7 REMARK 465 THR A 8 REMARK 465 GLU A 9 REMARK 465 ILE A 10 REMARK 465 VAL A 11 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 LEU B 3 REMARK 465 THR B 4 REMARK 465 GLN B 5 REMARK 465 VAL B 6 REMARK 465 GLU B 7 REMARK 465 THR B 8 REMARK 465 GLU B 9 REMARK 465 ILE B 10 REMARK 465 VAL B 11 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR B 207 OE2 GLU B 334 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS B 291 CE LYS B 291 NZ -0.153 REMARK 500 GLU B 292 CG GLU B 292 CD -0.117 REMARK 500 GLU B 292 CD GLU B 292 OE1 -0.111 REMARK 500 GLU B 292 CD GLU B 292 OE2 -0.126 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 256 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 ARG A 272 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 ALA B 293 N - CA - C ANGL. DEV. = 18.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 72 23.70 -78.90 REMARK 500 ARG A 188 35.10 -150.14 REMARK 500 PHE A 197 125.36 -30.27 REMARK 500 LYS A 198 -10.77 61.19 REMARK 500 PRO A 256 30.17 -54.91 REMARK 500 ARG A 311 -40.62 -147.46 REMARK 500 ALA A 312 42.01 -103.96 REMARK 500 ASN A 336 34.66 -99.29 REMARK 500 ALA A 354 42.84 -142.04 REMARK 500 ASN A 355 3.50 -69.94 REMARK 500 PHE A 398 28.91 48.76 REMARK 500 TYR A 509 120.39 -27.98 REMARK 500 GLU B 18 -41.80 -133.05 REMARK 500 ARG B 188 1.20 -64.10 REMARK 500 PHE B 197 123.99 -38.76 REMARK 500 LYS B 198 -9.53 66.79 REMARK 500 PRO B 256 44.40 -63.74 REMARK 500 ARG B 311 -30.33 -134.97 REMARK 500 ALA B 354 43.63 -143.27 REMARK 500 TYR B 393 61.12 74.28 REMARK 500 GLN B 433 30.29 -91.93 REMARK 500 GLN B 442 70.94 -101.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 295 A 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OHY RELATED DB: PDB REMARK 900 NATIVE SGTAM STUCTURE REMARK 900 RELATED ID: 2QVE RELATED DB: PDB REMARK 900 SGTAM BOUND WITH PRODUCT MIMIC REMARK 900 RELATED ID: 2RJS RELATED DB: PDB DBREF 2RJR A 1 539 UNP Q8GMG0 Q8GMG0_STRGL 1 539 DBREF 2RJR B 1 539 UNP Q8GMG0 Q8GMG0_STRGL 1 539 SEQRES 1 A 537 MET ALA LEU THR GLN VAL GLU THR GLU ILE VAL PRO VAL SEQRES 2 A 537 SER VAL ASP GLY GLU THR LEU THR VAL GLU ALA VAL ARG SEQRES 3 A 537 ARG VAL ALA GLU GLU ARG ALA THR VAL ASP VAL PRO ALA SEQRES 4 A 537 GLU SER ILE ALA LYS ALA GLN LYS SER ARG GLU ILE PHE SEQRES 5 A 537 GLU GLY ILE ALA GLU GLN ASN ILE PRO ILE TYR GLY VAL SEQRES 6 A 537 THR THR GLY TYR GLY GLU MET ILE TYR MET GLN VAL ASP SEQRES 7 A 537 LYS SER LYS GLU VAL GLU LEU GLN THR ASN LEU VAL ARG SEQRES 8 A 537 SER HIS SER ALA GLY VAL GLY PRO LEU PHE ALA GLU ASP SEQRES 9 A 537 GLU ALA ARG ALA ILE VAL ALA ALA ARG LEU ASN THR LEU SEQRES 10 A 537 ALA LYS GLY HIS SER ALA VAL ARG PRO ILE ILE LEU GLU SEQRES 11 A 537 ARG LEU ALA GLN TYR LEU ASN GLU GLY ILE THR PRO ALA SEQRES 12 A 537 ILE PRO GLU ILE GLY SER LEU GLY MDO ASP LEU ALA PRO SEQRES 13 A 537 LEU SER HIS VAL ALA SER THR LEU ILE GLY GLU GLY TYR SEQRES 14 A 537 VAL LEU ARG ASP GLY ARG PRO VAL GLU THR ALA GLN VAL SEQRES 15 A 537 LEU ALA GLU ARG GLY ILE GLU PRO LEU GLU LEU ARG PHE SEQRES 16 A 537 LYS GLU GLY LEU ALA LEU ILE ASN GLY THR SER GLY MET SEQRES 17 A 537 THR GLY LEU GLY SER LEU VAL VAL GLY ARG ALA LEU GLU SEQRES 18 A 537 GLN ALA GLN GLN ALA GLU ILE VAL THR ALA LEU LEU ILE SEQRES 19 A 537 GLU ALA VAL ARG GLY SER THR SER PRO PHE LEU ALA GLU SEQRES 20 A 537 GLY HIS ASP ILE ALA ARG PRO HIS GLU GLY GLN ILE ASP SEQRES 21 A 537 THR ALA ALA ASN MET ARG ALA LEU MET ARG GLY SER GLY SEQRES 22 A 537 LEU THR VAL GLU HIS ALA ASP LEU ARG ARG GLU LEU GLN SEQRES 23 A 537 LYS ASP LYS GLU ALA GLY LYS ASP VAL GLN ARG SER GLU SEQRES 24 A 537 ILE TYR LEU GLN LYS ALA TYR SER LEU ARG ALA ILE PRO SEQRES 25 A 537 GLN VAL VAL GLY ALA VAL ARG ASP THR LEU TYR HIS ALA SEQRES 26 A 537 ARG HIS LYS LEU ARG ILE GLU LEU ASN SER ALA ASN ASP SEQRES 27 A 537 ASN PRO LEU PHE PHE GLU GLY LYS GLU ILE PHE HIS GLY SEQRES 28 A 537 ALA ASN PHE HIS GLY GLN PRO ILE ALA PHE ALA MET ASP SEQRES 29 A 537 PHE VAL THR ILE ALA LEU THR GLN LEU GLY VAL LEU ALA SEQRES 30 A 537 GLU ARG GLN ILE ASN ARG VAL LEU ASN ARG HIS LEU SER SEQRES 31 A 537 TYR GLY LEU PRO GLU PHE LEU VAL SER GLY ASP PRO GLY SEQRES 32 A 537 LEU HIS SER GLY PHE ALA GLY ALA GLN TYR PRO ALA THR SEQRES 33 A 537 ALA LEU VAL ALA GLU ASN ARG THR ILE GLY PRO ALA SER SEQRES 34 A 537 THR GLN SER VAL PRO SER ASN GLY ASP ASN GLN ASP VAL SEQRES 35 A 537 VAL SER MET GLY LEU ILE SER ALA ARG ASN ALA ARG ARG SEQRES 36 A 537 VAL LEU SER ASN ASN ASN LYS ILE LEU ALA VAL GLU TYR SEQRES 37 A 537 LEU ALA ALA ALA GLN ALA VAL ASP ILE SER GLY ARG PHE SEQRES 38 A 537 ASP GLY LEU SER PRO ALA ALA LYS ALA THR TYR GLU ALA SEQRES 39 A 537 VAL ARG ARG LEU VAL PRO THR LEU GLY VAL ASP ARG TYR SEQRES 40 A 537 MET ALA ASP ASP ILE GLU LEU VAL ALA ASP ALA LEU SER SEQRES 41 A 537 ARG GLY GLU PHE LEU ARG ALA ILE ALA ARG GLU THR ASP SEQRES 42 A 537 ILE GLN LEU ARG SEQRES 1 B 537 MET ALA LEU THR GLN VAL GLU THR GLU ILE VAL PRO VAL SEQRES 2 B 537 SER VAL ASP GLY GLU THR LEU THR VAL GLU ALA VAL ARG SEQRES 3 B 537 ARG VAL ALA GLU GLU ARG ALA THR VAL ASP VAL PRO ALA SEQRES 4 B 537 GLU SER ILE ALA LYS ALA GLN LYS SER ARG GLU ILE PHE SEQRES 5 B 537 GLU GLY ILE ALA GLU GLN ASN ILE PRO ILE TYR GLY VAL SEQRES 6 B 537 THR THR GLY TYR GLY GLU MET ILE TYR MET GLN VAL ASP SEQRES 7 B 537 LYS SER LYS GLU VAL GLU LEU GLN THR ASN LEU VAL ARG SEQRES 8 B 537 SER HIS SER ALA GLY VAL GLY PRO LEU PHE ALA GLU ASP SEQRES 9 B 537 GLU ALA ARG ALA ILE VAL ALA ALA ARG LEU ASN THR LEU SEQRES 10 B 537 ALA LYS GLY HIS SER ALA VAL ARG PRO ILE ILE LEU GLU SEQRES 11 B 537 ARG LEU ALA GLN TYR LEU ASN GLU GLY ILE THR PRO ALA SEQRES 12 B 537 ILE PRO GLU ILE GLY SER LEU GLY MDO ASP LEU ALA PRO SEQRES 13 B 537 LEU SER HIS VAL ALA SER THR LEU ILE GLY GLU GLY TYR SEQRES 14 B 537 VAL LEU ARG ASP GLY ARG PRO VAL GLU THR ALA GLN VAL SEQRES 15 B 537 LEU ALA GLU ARG GLY ILE GLU PRO LEU GLU LEU ARG PHE SEQRES 16 B 537 LYS GLU GLY LEU ALA LEU ILE ASN GLY THR SER GLY MET SEQRES 17 B 537 THR GLY LEU GLY SER LEU VAL VAL GLY ARG ALA LEU GLU SEQRES 18 B 537 GLN ALA GLN GLN ALA GLU ILE VAL THR ALA LEU LEU ILE SEQRES 19 B 537 GLU ALA VAL ARG GLY SER THR SER PRO PHE LEU ALA GLU SEQRES 20 B 537 GLY HIS ASP ILE ALA ARG PRO HIS GLU GLY GLN ILE ASP SEQRES 21 B 537 THR ALA ALA ASN MET ARG ALA LEU MET ARG GLY SER GLY SEQRES 22 B 537 LEU THR VAL GLU HIS ALA ASP LEU ARG ARG GLU LEU GLN SEQRES 23 B 537 LYS ASP LYS GLU ALA GLY LYS ASP VAL GLN ARG SER GLU SEQRES 24 B 537 ILE TYR LEU GLN LYS ALA TYR SER LEU ARG ALA ILE PRO SEQRES 25 B 537 GLN VAL VAL GLY ALA VAL ARG ASP THR LEU TYR HIS ALA SEQRES 26 B 537 ARG HIS LYS LEU ARG ILE GLU LEU ASN SER ALA ASN ASP SEQRES 27 B 537 ASN PRO LEU PHE PHE GLU GLY LYS GLU ILE PHE HIS GLY SEQRES 28 B 537 ALA ASN PHE HIS GLY GLN PRO ILE ALA PHE ALA MET ASP SEQRES 29 B 537 PHE VAL THR ILE ALA LEU THR GLN LEU GLY VAL LEU ALA SEQRES 30 B 537 GLU ARG GLN ILE ASN ARG VAL LEU ASN ARG HIS LEU SER SEQRES 31 B 537 TYR GLY LEU PRO GLU PHE LEU VAL SER GLY ASP PRO GLY SEQRES 32 B 537 LEU HIS SER GLY PHE ALA GLY ALA GLN TYR PRO ALA THR SEQRES 33 B 537 ALA LEU VAL ALA GLU ASN ARG THR ILE GLY PRO ALA SER SEQRES 34 B 537 THR GLN SER VAL PRO SER ASN GLY ASP ASN GLN ASP VAL SEQRES 35 B 537 VAL SER MET GLY LEU ILE SER ALA ARG ASN ALA ARG ARG SEQRES 36 B 537 VAL LEU SER ASN ASN ASN LYS ILE LEU ALA VAL GLU TYR SEQRES 37 B 537 LEU ALA ALA ALA GLN ALA VAL ASP ILE SER GLY ARG PHE SEQRES 38 B 537 ASP GLY LEU SER PRO ALA ALA LYS ALA THR TYR GLU ALA SEQRES 39 B 537 VAL ARG ARG LEU VAL PRO THR LEU GLY VAL ASP ARG TYR SEQRES 40 B 537 MET ALA ASP ASP ILE GLU LEU VAL ALA ASP ALA LEU SER SEQRES 41 B 537 ARG GLY GLU PHE LEU ARG ALA ILE ALA ARG GLU THR ASP SEQRES 42 B 537 ILE GLN LEU ARG MODRES 2RJR MDO A 152 ALA MODRES 2RJR MDO A 152 SER MODRES 2RJR MDO A 152 GLY MODRES 2RJR MDO B 152 ALA MODRES 2RJR MDO B 152 SER MODRES 2RJR MDO B 152 GLY HET MDO A 152 13 HET MDO B 152 13 HET 295 A1001 14 HETNAM MDO {2-[(1S)-1-AMINOETHYL]-4-METHYLIDENE-5-OXO-4,5-DIHYDRO- HETNAM 2 MDO 1H-IMIDAZOL-1-YL}ACETIC ACID HETNAM 295 (2S,3S)-3-(4-FLUOROPHENYL)-2,3-DIHYDROXYPROPANOIC ACID HETSYN MDO 4-METHYLIDENE-5-ONE; PEPTIDE DERIVED CHROMOPHORE FORMUL 1 MDO 2(C8 H11 N3 O3) FORMUL 3 295 C9 H9 F O4 FORMUL 4 HOH *473(H2 O) HELIX 1 1 THR A 21 GLU A 31 1 11 HELIX 2 2 PRO A 38 GLU A 57 1 20 HELIX 3 3 TYR A 69 ILE A 73 5 5 HELIX 4 4 LYS A 81 SER A 94 1 14 HELIX 5 5 ALA A 102 ALA A 118 1 17 HELIX 6 6 ARG A 125 GLY A 139 1 15 HELIX 7 7 ASP A 155 ILE A 167 1 13 HELIX 8 8 THR A 181 GLU A 187 1 7 HELIX 9 9 LYS A 198 ASN A 205 1 8 HELIX 10 10 THR A 207 VAL A 239 1 33 HELIX 11 11 THR A 243 LEU A 247 5 5 HELIX 12 12 ALA A 248 ILE A 253 1 6 HELIX 13 13 HIS A 257 MET A 271 1 15 HELIX 14 14 GLU A 279 LYS A 291 1 13 HELIX 15 15 ALA A 307 ARG A 311 5 5 HELIX 16 16 ALA A 312 ASN A 336 1 25 HELIX 17 17 GLY A 358 ASN A 388 1 31 HELIX 18 18 PRO A 396 VAL A 400 5 5 HELIX 19 19 PHE A 410 THR A 426 1 17 HELIX 20 20 MET A 447 GLY A 481 1 35 HELIX 21 21 ARG A 482 LEU A 486 5 5 HELIX 22 22 SER A 487 VAL A 501 1 15 HELIX 23 23 MET A 510 GLY A 524 1 15 HELIX 24 24 GLY A 524 THR A 534 1 11 HELIX 25 25 THR B 21 ARG B 32 1 12 HELIX 26 26 PRO B 38 GLU B 57 1 20 HELIX 27 27 TYR B 69 ILE B 73 5 5 HELIX 28 28 LYS B 81 HIS B 93 1 13 HELIX 29 29 ALA B 102 LYS B 119 1 18 HELIX 30 30 ARG B 125 GLY B 139 1 15 HELIX 31 31 ASP B 155 ILE B 167 1 13 HELIX 32 32 THR B 181 GLY B 189 1 9 HELIX 33 33 LYS B 198 ASN B 205 1 8 HELIX 34 34 THR B 207 VAL B 239 1 33 HELIX 35 35 THR B 243 LEU B 247 5 5 HELIX 36 36 ALA B 248 ILE B 253 1 6 HELIX 37 37 HIS B 257 MET B 271 1 15 HELIX 38 38 GLU B 279 LYS B 291 1 13 HELIX 39 39 ALA B 307 ARG B 311 5 5 HELIX 40 40 ALA B 312 ASN B 336 1 25 HELIX 41 41 GLY B 358 ASN B 388 1 31 HELIX 42 42 PRO B 396 VAL B 400 5 5 HELIX 43 43 PHE B 410 ARG B 425 1 16 HELIX 44 44 MET B 447 GLY B 481 1 35 HELIX 45 45 ARG B 482 LEU B 486 5 5 HELIX 46 46 SER B 487 VAL B 501 1 15 HELIX 47 47 MET B 510 ARG B 523 1 14 HELIX 48 48 GLY B 524 THR B 534 1 11 SHEET 1 A 2 VAL A 13 SER A 14 0 SHEET 2 A 2 VAL A 35 ASP A 36 1 O ASP A 36 N VAL A 13 SHEET 1 B 2 MET A 75 VAL A 77 0 SHEET 2 B 2 VAL B 297 ARG B 299 -1 O GLN B 298 N GLN A 76 SHEET 1 C 2 VAL A 97 LEU A 100 0 SHEET 2 C 2 PRO A 145 ILE A 147 -1 O GLU A 146 N PRO A 99 SHEET 1 D 2 TYR A 171 ARG A 174 0 SHEET 2 D 2 ARG A 177 GLU A 180 -1 O VAL A 179 N VAL A 172 SHEET 1 E 2 VAL A 297 ARG A 299 0 SHEET 2 E 2 MET B 75 VAL B 77 -1 O GLN B 76 N GLN A 298 SHEET 1 F 2 VAL B 13 SER B 14 0 SHEET 2 F 2 VAL B 35 ASP B 36 1 O ASP B 36 N VAL B 13 SHEET 1 G 2 VAL B 97 LEU B 100 0 SHEET 2 G 2 PRO B 145 ILE B 147 -1 O GLU B 146 N PRO B 99 SHEET 1 H 2 TYR B 171 ARG B 174 0 SHEET 2 H 2 ARG B 177 GLU B 180 -1 O VAL B 179 N VAL B 172 LINK C GLY A 151 N1 MDO A 152 1555 1555 1.32 LINK C3 MDO A 152 N ASP A 155 1555 1555 1.30 LINK CB2 MDO A 152 O3 295 A1001 1555 1555 1.40 LINK C GLY B 151 N1 MDO B 152 1555 1555 1.34 LINK C3 MDO B 152 N ASP B 155 1555 1555 1.35 CISPEP 1 ASN A 341 PRO A 342 0 -0.28 CISPEP 2 ASN B 341 PRO B 342 0 -0.34 SITE 1 AC1 12 TYR A 63 GLY A 70 HIS A 93 MDO A 152 SITE 2 AC1 12 LEU A 156 LEU A 201 ASN A 205 PHE A 356 SITE 3 AC1 12 TYR A 415 GLN A 442 TYR B 308 ARG B 311 CRYST1 92.245 145.648 75.114 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010841 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006866 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013313 0.00000